
Biobanking Industry Research Report 2024
Description
Biobanking Industry Research Report 2024
Summary
Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.
According to APO Research, The global Biobanking market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Biobanking is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Biobanking is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Biobanking is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Biobanking include Thermo Fisher, Beckman Coulter, Panasonic, SOL Group, Promega, Merck, Greiner Bio One, Chart Industries and Brooks Life Science, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biobanking, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biobanking.
The Biobanking market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biobanking market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Thermo Fisher
Beckman Coulter
Panasonic
SOL Group
Promega
Merck
Greiner Bio One
Chart Industries
Brooks Life Science
Tecan Group
QIAGEN
BD
Lifeline Scientific
Hamilton
So-Low
TTP Labtech Ltd
Biolife Solutions
DNA Genotek
Custom Biogenic Systems
LVL Technologies
BioRep
Biobanking segment by Type
Equipment
Consumable
Biobanking Segment by Application
Virtual Biobanks
Tissue Biobanks
Population Biobanks
Biobanking Segment by Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biobanking market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biobanking and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biobanking.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biobanking companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Table of Contents
141 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Biobanking by Type
- 2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
- 2.2.2 Equipment
- 2.2.3 Consumable
- 2.3 Biobanking by Application
- 2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
- 2.3.2 Virtual Biobanks
- 2.3.3 Tissue Biobanks
- 2.3.4 Population Biobanks
- 2.4 Assumptions and Limitations
- 3 Biobanking Breakdown Data by Type
- 3.1 Global Biobanking Historic Market Size by Type (2019-2024)
- 3.2 Global Biobanking Forecasted Market Size by Type (2025-2030)
- 4 Biobanking Breakdown Data by Application
- 4.1 Global Biobanking Historic Market Size by Application (2019-2024)
- 4.2 Global Biobanking Forecasted Market Size by Application (2019-2024)
- 5 Global Growth Trends
- 5.1 Global Biobanking Market Perspective (2019-2030)
- 5.2 Global Biobanking Growth Trends by Region
- 5.2.1 Global Biobanking Market Size by Region: 2019 VS 2023 VS 2030
- 5.2.2 Biobanking Historic Market Size by Region (2019-2024)
- 5.2.3 Biobanking Forecasted Market Size by Region (2025-2030)
- 5.3 Biobanking Market Dynamics
- 5.3.1 Biobanking Industry Trends
- 5.3.2 Biobanking Market Drivers
- 5.3.3 Biobanking Market Challenges
- 5.3.4 Biobanking Market Restraints
- 6 Market Competitive Landscape by Players
- 6.1 Global Top Biobanking Players by Revenue
- 6.1.1 Global Top Biobanking Players by Revenue (2019-2024)
- 6.1.2 Global Biobanking Revenue Market Share by Players (2019-2024)
- 6.2 Global Biobanking Industry Players Ranking, 2022 VS 2023 VS 2024
- 6.3 Global Key Players of Biobanking Head office and Area Served
- 6.4 Global Biobanking Players, Product Type & Application
- 6.5 Global Biobanking Players, Date of Enter into This Industry
- 6.6 Global Biobanking Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
- 7 North America
- 7.1 North America Biobanking Market Size (2019-2030)
- 7.2 North America Biobanking Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 7.3 North America Biobanking Market Size by Country (2019-2024)
- 7.4 North America Biobanking Market Size by Country (2025-2030)
- 7.5 United States
- 7.6 Canada
- 8 Europe
- 8.1 Europe Biobanking Market Size (2019-2030)
- 8.2 Europe Biobanking Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 8.3 Europe Biobanking Market Size by Country (2019-2024)
- 8.4 Europe Biobanking Market Size by Country (2025-2030)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Russia
- 8.10 Nordic Countries
- 9 Asia-Pacific
- 9.1 Asia-Pacific Biobanking Market Size (2019-2030)
- 9.2 Asia-Pacific Biobanking Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 9.3 Asia-Pacific Biobanking Market Size by Country (2019-2024)
- 9.4 Asia-Pacific Biobanking Market Size by Country (2025-2030)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 Southeast Asia
- 9.9 India
- 9.10 Australia
- 10 Latin America
- 10.1 Latin America Biobanking Market Size (2019-2030)
- 10.2 Latin America Biobanking Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 10.3 Latin America Biobanking Market Size by Country (2019-2024)
- 10.4 Latin America Biobanking Market Size by Country (2025-2030)
- 10.5 Mexico
- 10.6 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Biobanking Market Size (2019-2030)
- 11.2 Middle East & Africa Biobanking Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 11.3 Middle East & Africa Biobanking Market Size by Country (2019-2024)
- 11.4 Middle East & Africa Biobanking Market Size by Country (2025-2030)
- 11.5 Turkey
- 11.6 Saudi Arabia
- 11.7 UAE
- 12 Players Profiled
- 12.1 Thermo Fisher
- 12.1.1 Thermo Fisher Company Information
- 12.1.2 Thermo Fisher Business Overview
- 12.1.3 Thermo Fisher Revenue in Biobanking Business (2019-2024)
- 12.1.4 Thermo Fisher Biobanking Product Portfolio
- 12.1.5 Thermo Fisher Recent Developments
- 12.2 Beckman Coulter
- 12.2.1 Beckman Coulter Company Information
- 12.2.2 Beckman Coulter Business Overview
- 12.2.3 Beckman Coulter Revenue in Biobanking Business (2019-2024)
- 12.2.4 Beckman Coulter Biobanking Product Portfolio
- 12.2.5 Beckman Coulter Recent Developments
- 12.3 Panasonic
- 12.3.1 Panasonic Company Information
- 12.3.2 Panasonic Business Overview
- 12.3.3 Panasonic Revenue in Biobanking Business (2019-2024)
- 12.3.4 Panasonic Biobanking Product Portfolio
- 12.3.5 Panasonic Recent Developments
- 12.4 SOL Group
- 12.4.1 SOL Group Company Information
- 12.4.2 SOL Group Business Overview
- 12.4.3 SOL Group Revenue in Biobanking Business (2019-2024)
- 12.4.4 SOL Group Biobanking Product Portfolio
- 12.4.5 SOL Group Recent Developments
- 12.5 Promega
- 12.5.1 Promega Company Information
- 12.5.2 Promega Business Overview
- 12.5.3 Promega Revenue in Biobanking Business (2019-2024)
- 12.5.4 Promega Biobanking Product Portfolio
- 12.5.5 Promega Recent Developments
- 12.6 Merck
- 12.6.1 Merck Company Information
- 12.6.2 Merck Business Overview
- 12.6.3 Merck Revenue in Biobanking Business (2019-2024)
- 12.6.4 Merck Biobanking Product Portfolio
- 12.6.5 Merck Recent Developments
- 12.7 Greiner Bio One
- 12.7.1 Greiner Bio One Company Information
- 12.7.2 Greiner Bio One Business Overview
- 12.7.3 Greiner Bio One Revenue in Biobanking Business (2019-2024)
- 12.7.4 Greiner Bio One Biobanking Product Portfolio
- 12.7.5 Greiner Bio One Recent Developments
- 12.8 Chart Industries
- 12.8.1 Chart Industries Company Information
- 12.8.2 Chart Industries Business Overview
- 12.8.3 Chart Industries Revenue in Biobanking Business (2019-2024)
- 12.8.4 Chart Industries Biobanking Product Portfolio
- 12.8.5 Chart Industries Recent Developments
- 12.9 Brooks Life Science
- 12.9.1 Brooks Life Science Company Information
- 12.9.2 Brooks Life Science Business Overview
- 12.9.3 Brooks Life Science Revenue in Biobanking Business (2019-2024)
- 12.9.4 Brooks Life Science Biobanking Product Portfolio
- 12.9.5 Brooks Life Science Recent Developments
- 12.10 Tecan Group
- 12.10.1 Tecan Group Company Information
- 12.10.2 Tecan Group Business Overview
- 12.10.3 Tecan Group Revenue in Biobanking Business (2019-2024)
- 12.10.4 Tecan Group Biobanking Product Portfolio
- 12.10.5 Tecan Group Recent Developments
- 12.11 QIAGEN
- 12.11.1 QIAGEN Company Information
- 12.11.2 QIAGEN Business Overview
- 12.11.3 QIAGEN Revenue in Biobanking Business (2019-2024)
- 12.11.4 QIAGEN Biobanking Product Portfolio
- 12.11.5 QIAGEN Recent Developments
- 12.12 BD
- 12.12.1 BD Company Information
- 12.12.2 BD Business Overview
- 12.12.3 BD Revenue in Biobanking Business (2019-2024)
- 12.12.4 BD Biobanking Product Portfolio
- 12.12.5 BD Recent Developments
- 12.13 Lifeline Scientific
- 12.13.1 Lifeline Scientific Company Information
- 12.13.2 Lifeline Scientific Business Overview
- 12.13.3 Lifeline Scientific Revenue in Biobanking Business (2019-2024)
- 12.13.4 Lifeline Scientific Biobanking Product Portfolio
- 12.13.5 Lifeline Scientific Recent Developments
- 12.14 Hamilton
- 12.14.1 Hamilton Company Information
- 12.14.2 Hamilton Business Overview
- 12.14.3 Hamilton Revenue in Biobanking Business (2019-2024)
- 12.14.4 Hamilton Biobanking Product Portfolio
- 12.14.5 Hamilton Recent Developments
- 12.15 So-Low
- 12.15.1 So-Low Company Information
- 12.15.2 So-Low Business Overview
- 12.15.3 So-Low Revenue in Biobanking Business (2019-2024)
- 12.15.4 So-Low Biobanking Product Portfolio
- 12.15.5 So-Low Recent Developments
- 12.16 TTP Labtech Ltd
- 12.16.1 TTP Labtech Ltd Company Information
- 12.16.2 TTP Labtech Ltd Business Overview
- 12.16.3 TTP Labtech Ltd Revenue in Biobanking Business (2019-2024)
- 12.16.4 TTP Labtech Ltd Biobanking Product Portfolio
- 12.16.5 TTP Labtech Ltd Recent Developments
- 12.17 Biolife Solutions
- 12.17.1 Biolife Solutions Company Information
- 12.17.2 Biolife Solutions Business Overview
- 12.17.3 Biolife Solutions Revenue in Biobanking Business (2019-2024)
- 12.17.4 Biolife Solutions Biobanking Product Portfolio
- 12.17.5 Biolife Solutions Recent Developments
- 12.18 DNA Genotek
- 12.18.1 DNA Genotek Company Information
- 12.18.2 DNA Genotek Business Overview
- 12.18.3 DNA Genotek Revenue in Biobanking Business (2019-2024)
- 12.18.4 DNA Genotek Biobanking Product Portfolio
- 12.18.5 DNA Genotek Recent Developments
- 12.19 Custom Biogenic Systems
- 12.19.1 Custom Biogenic Systems Company Information
- 12.19.2 Custom Biogenic Systems Business Overview
- 12.19.3 Custom Biogenic Systems Revenue in Biobanking Business (2019-2024)
- 12.19.4 Custom Biogenic Systems Biobanking Product Portfolio
- 12.19.5 Custom Biogenic Systems Recent Developments
- 12.20 LVL Technologies
- 12.20.1 LVL Technologies Company Information
- 12.20.2 LVL Technologies Business Overview
- 12.20.3 LVL Technologies Revenue in Biobanking Business (2019-2024)
- 12.20.4 LVL Technologies Biobanking Product Portfolio
- 12.20.5 LVL Technologies Recent Developments
- 12.21 BioRep
- 12.21.1 BioRep Company Information
- 12.21.2 BioRep Business Overview
- 12.21.3 BioRep Revenue in Biobanking Business (2019-2024)
- 12.21.4 BioRep Biobanking Product Portfolio
- 12.21.5 BioRep Recent Developments
- 13 Report Conclusion
- 14 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.